| 1 |
33190190 | Clinical Challenges in the Management of Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer: A Literature Review. | 2021 Jan |
1 |
| 2 |
30622925 | Current status of PI3K-mTOR inhibition in hormone-receptor positive, HER2-negative breast cancer. | 2018 Dec 20 |
1 |
| 3 |
27217461 | Endocrine Therapy for Hormone Receptor-Positive Metastatic Breast Cancer: American Society of Clinical Oncology Guideline. | 2016 Sep 1 |
1 |
| 4 |
26207713 | Stomatitis Associated With Use of mTOR Inhibitors: Implications for Patients With Invasive Breast Cancer. | 2015 Aug |
2 |
| 5 |
24559450 | mTOR inhibitors: changing landscape of endocrine-resistant breast cancer. | 2014 Feb |
1 |
| 6 |
24691195 | [Exemestane-everolimus in HER2-negative, hormonal receptor-positive, post-menopausal metastatic breast cancer with resistance to non-steroidal aromatase inhibitor: a new option]. | 2014 Mar |
1 |
| 7 |
25302045 | Severe gastrointestinal hemorrhage during targeted therapy for advanced breast carcinoma. | 2014 Oct |
1 |
| 8 |
25419366 | Mammalian target of rapamycin (mTOR) inhibitors and combined chemotherapy in breast cancer: a meta-analysis of randomized controlled trials. | 2014 |
1 |
| 9 |
23299092 | Advances in the treatment of luminal breast cancer. | 2013 Feb |
1 |
| 10 |
23686401 | Management of adverse events in patients with hormone receptor-positive breast cancer treated with everolimus: observations from a phase III clinical trial. | 2013 Aug |
1 |
| 11 |
23714446 | Treatment algorithms for hormone receptor-positive advanced breast cancer: applying the results from recent clinical trials into daily practice—insights, limitations, and moving forward. | 2013 |
2 |
| 12 |
23814023 | Dual inhibition of PI3K and mTOR mitigates compensatory AKT activation and improves tamoxifen response in breast cancer. | 2013 Oct |
1 |
| 13 |
23907751 | Everolimus: side effect profile and management of toxicities in breast cancer. | 2013 Aug |
1 |
| 14 |
22713135 | BOLERO-2 - will this change practice in advanced breast cancer? | 2012 Jun 19 |
2 |